Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue
- 1 June 2023
- journal article
- research article
- Published by Elsevier BV in Pregnancy Hypertension
- Vol. 32, 43-49
- https://doi.org/10.1016/j.preghy.2023.04.001
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Eculizumab for the treatment of preeclampsia/HELLP syndromePlacenta, 2013
- Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysisEuropean Journal of Epidemiology, 2013
- Autoantibody-Mediated Complement C3a Receptor Activation Contributes to the Pathogenesis of PreeclampsiaHypertension, 2012
- Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with PreeclampsiaAmerican Journal of Reproductive Immunology, 2012
- Activation of the complement system in normal pregnancy and preeclampsiaMolecular Immunology, 2010
- Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndromeVirchows Archiv, 2008
- Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restrictionThe Journal of Experimental Medicine, 2006
- Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentaeClinical and Experimental Immunology, 1990